Healthcare stocks were trading in the positive zone, with the S&P BSE Healthcare index rising 119.43 points or 0.56% at 21594.79 at 09:48 IST.
Among the components of the S&P BSE Healthcare index, Marksans Pharma Ltd (up 5.42%), Suven Pharmaceuticals Ltd (up 4.41%),Novartis India Ltd (up 3.99%),Morepen Laboratories Ltd (up 3.83%),Neuland Laboratories Ltd (up 2.79%), were the top gainers. Among the other gainers were Alembic Ltd (up 2.79%), RPG Life Sciences Ltd (up 2.43%), Glenmark Pharmaceuticals Ltd (up 2.29%), Strides Pharma Science Ltd (up 2.04%), and Indoco Remedies Ltd (up 2.04%).
On the other hand, Suven Life Sciences Ltd (down 4.96%), Dishman Carbogen Amcis Ltd (down 2.6%), and IOL Chemicals & Pharmaceuticals Ltd (down 2.15%) moved lower.
At 09:48 IST, the S&P BSE Sensex was down 11.21 or 0.02% at 46949.48.
The Nifty 50 index was down 28.45 points or 0.21% at 13732.1.
The S&P BSE Small-Cap index was up 15.21 points or 0.09% at 17784.31.
The S&P BSE 150 Midcap Index index was down 15.13 points or 0.26% at 5907.57.
On BSE,1042 shares were trading in green, 1203 were trading in red and 91 were unchanged.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU